No data available
Our Biosciences Team has advised on a wide variety of matters including research and development agreements, patent and know how licences and assignments, manufacturing agreements, bioinformatics, regulatory matters, clinical trials, patent litigation and competition law. The members of the Biosciences Team pride themselves on their responsive, hands-on and pro-active approach. This includes helping to find venture capital finance for clients through the firm's extensive corporate finance network and advising on intellectual property protection and exploitation. Osborne Clarke recognises that biotechnology companies want to deal with a team of specialists whose experience ensures technically accurate and commercial, pragmatic advice.. . Biotechnology agreements, collaborations, research and devleopment agreements, venture capital and other funding arrangements for biotechnology companies. Represented in most major European jurisdictions and in Silicon Valley.. . Bioinformatics, law, European law, research, colllaboration, contract research, intellectual property, patents, financing, competition law, technology transfer, mergers and acquisitions, due diligence, regulatory matters.
No data available
Sustainable bio-based materials for fashion
Paspigioni is a full-service contract research organization that supports pharmaceutical and biotechnology companies in conducting interventional and non-interventional clinical trials across phases I—IV.
Our award-winning life sciences team is led by highly-ranked lawyers who advise companies in the biotech, pharmaceutical, diagnostics, veterinary and healthcare sectors. We add value with lawyers who understand the science from their degree subjects, and understand your business, having worked in-house for life science companies, or with them for many years. We act for companies, at all stages of their life cycle, including global pharmaceutical companies, larger plcs and SMEs, together with research organisations, venture capital funds and universities. 'Impressive IP practice acting for life sciences businesses, universities and their spinoffs… Recommended for licence and research agreements.' - Chambers 2017.
Perla Development is a training, facilitation and executive coaching consultancy, specialising in leadership, management and professional development, (primarily within the life sciences sector). Founded in 2014, and run by Liz Mercer, Perla Development offers executive coaching, leadership and management development programmes, workshop design and delivery, team development and meetings facilitation.
Perla’s flagship development programme is the Management Essentials Programme for first line leaders which has been running since 2022. Commencing in February 2026, (in partnership with Matt Evans of Fired-Up Talent), the Expert Leader Programme will also be running for middle to senior leaders in the life sciences.
Both these programmes are open programmes with participation from across the industry. Liz also works with many clients providing training and development in a variety of topics: coaching skills, feedback, delegation, difficult conversations, managing performance, leading change, motivation and engagement, to name but a few. Her recent clients include, OMass Therapeutics, Charm Therapeutics, Microbiotica Ltd, T-therapeutics, Alchemab, Vernalis, Besins Healthcare and Ensocell.
Liz utilises a number of industry-leading models and tools in her work such as the Myers Briggs Type Indicator (MBTI), Korn Ferry competencies, Hogan, 360 feedback tools and the Key Polarity Indicator.
Perla Development is offering a discount to One Nucleus members. For more information please see https://onenucleus.com/perla-development
To get in touch with Liz at Perla Development you can:
• message directly, or call 07825 229686
• email her at [email protected]
• or message via LinkedIn https://www.linkedin.com/in/lizmercer1/
Perla’s flagship development programme is the Management Essentials Programme for first line leaders which has been running since 2022. Commencing in February 2026, (in partnership with Matt Evans of Fired-Up Talent), the Expert Leader Programme will also be running for middle to senior leaders in the life sciences.
Both these programmes are open programmes with participation from across the industry. Liz also works with many clients providing training and development in a variety of topics: coaching skills, feedback, delegation, difficult conversations, managing performance, leading change, motivation and engagement, to name but a few. Her recent clients include, OMass Therapeutics, Charm Therapeutics, Microbiotica Ltd, T-therapeutics, Alchemab, Vernalis, Besins Healthcare and Ensocell.
Liz utilises a number of industry-leading models and tools in her work such as the Myers Briggs Type Indicator (MBTI), Korn Ferry competencies, Hogan, 360 feedback tools and the Key Polarity Indicator.
Perla Development is offering a discount to One Nucleus members. For more information please see https://onenucleus.com/perla-development
To get in touch with Liz at Perla Development you can:
• message directly, or call 07825 229686
• email her at [email protected]
• or message via LinkedIn https://www.linkedin.com/in/lizmercer1/
Pharma International provides global pharmaceutical regulatory consultancy services, with an emphasis on the emerging markets. Fully licensed by Swissmedic, Pharma International is authorised to trade in biotechnology, pharmaceuticals and medical devices internationally – as well as providing Swiss Qualified Person services. Seminars on regulatory affairs, especially Asia including ASEAN, China, Korea and India, are conducted regularly and can be adapted to in-house requirements.
Originally founded in 1996 and operating from laboratories in Royston, UK, Pharmagene Discovery Services (Pharmagene) is built upon the scientific knowledge, expertise and reputation of its legacy, and remains one of the earliest established companies to focus on human tissue-based research.
Pharmagene delivers tailored scientific solutions using human biospecimens in vitro to characterise disease and validate therapeutic targets & biomarkers to advance human health, from quantitative target expression, interrogation of spatial biology, functional cellular biology & bioassays, to biotherapeutic safety testing . The facility operates to GLP and is licenced by the UK Human Tissue Authority.
Pharmagene has created and curates an in-house human tissue biorepository to support research for its clients, and in addition offers sample processing and biostorage services.
With a wealth of knowledge of the human tissue research sector, and having conducted hundreds of studies for life science researchers around the world over the past three decades, the business is uniquely placed to support its clients to develop safe and efficacious new therapies and associated biomarkers more rapidly and with greater confidence.
Pharmagene delivers tailored scientific solutions using human biospecimens in vitro to characterise disease and validate therapeutic targets & biomarkers to advance human health, from quantitative target expression, interrogation of spatial biology, functional cellular biology & bioassays, to biotherapeutic safety testing . The facility operates to GLP and is licenced by the UK Human Tissue Authority.
Pharmagene has created and curates an in-house human tissue biorepository to support research for its clients, and in addition offers sample processing and biostorage services.
With a wealth of knowledge of the human tissue research sector, and having conducted hundreds of studies for life science researchers around the world over the past three decades, the business is uniquely placed to support its clients to develop safe and efficacious new therapies and associated biomarkers more rapidly and with greater confidence.
Regulatory Consultancy